Answers are grounded in this paper and cite their sources.
Internalised RGD peptide enhances the effects of co-administered drugs in pancreatic cancer models, its efficacy is however only appreciable in those employing cell lines. Therefore, the clinical application needs to be given careful consideration.
No takes yet. Share an insight, caveat, or question.
Akashi et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: